Newsroom
Spotlight Story
Decades of Dedication: UCB’s Ongoing Commitment to Epilepsy through the Family Epilepsy Scholarship Program™
Read more
Press Releases
Gen Z and Millennial Patients with Chronic Rheumatic Diseases Are Opening Up to Raise Awareness for…
Read More
UCB’s HS Summit United Patients and Experts to Drive Progress in Hidradenitis Suppurativa Awareness…
Read More
UCB extends its BIMZELX® “Get Yourself Back” direct-to-consumer campaign for the hidradenitis…
Read More
Inaugural 2025 UCB U.S. Myasthenia Gravis Scholarship™ grants 15 scholarships to people impacted by…
Read More
UCB Announces Major U.S. Investment to Expand Biologics Manufacturing Capacity
Read More
BIMZELX® (bimekizumab-bkzx) Three-Year Data at EULAR 2025 Showed Lasting Efficacy and Control of…
Read MoreUCB Stories
Gen Z and Millennial Patients Find “Rheum for Improvement” in Disease Management
Read More
The profound impact on the lives of people living with thymidine kinase 2 deficiency (TK2d)
Read More
The Sniff That Saves: Honoring Service Dogs This Awareness Month
Read More
Decades of Dedication: UCB’s Ongoing Commitment to Epilepsy through the Family Epilepsy Scholarship…
Read More
Our Growth Helps Elevate Patient Lives
Read More
